BRAF and lymphoma: Furthermore, when transplanted NSG mice were treated with a Mek inhibitor, a marked impairment of the ability of lymphoma cells to infiltrate other organs was observed, which indicates that the tumors are addicted to Braf-rs1 because they are addicted to the Erk pathway.